期刊文献+

兔抗hCG CP22抗血清体外抑制肿瘤细胞生长的研究

Inhibition of rabbit anti-hCG CP22 to tumor cells in vitro
原文传递
导出
摘要 目的:探讨抗原抗体反应检验若干人肿瘤细胞分泌β-hCG情况,和抗hCGCP22抗血清体外抑制肿瘤的作用。方法:采用细胞免疫荧光染色测定5个肿瘤细胞株是否表达β-hCG,用CCK-8试剂盒检测CP22抗血清(AS CP22)和β-hCG羧基端37肽(CTP)抗血清(AS CTP)体外抑制肿瘤细胞生长的光密度。结果:以AS CP22为探针和AS CTP为阳性对照,体外培养的人胰腺癌BXPC-3、人卵巢癌HO-8910和人结肠癌Lovo细胞膜上都能观察到绿色荧光,提示肿瘤细胞均表达β-hCG亚单位,而人前列腺癌PC-3和Du-145细胞则未检测到绿色荧光;与正常兔血清(NS)比较,AS CP22和AS CTP均可显著的体外抑制BXPC-3和HO-8910细胞生长,P<0.001。AS CP22抑制BXPC-3和HO-8910肿瘤细胞的作用都强于AS CTP,P<0.05。结论:人胰腺癌BXPC-3、人卵巢癌HO-8910和人结肠癌Lovo细胞在体外培养的情况下均表达β-hCG亚单位,且它们的体外生长都能被兔抗hCG嵌合肽(CP22)抗血清体外抑制。 OBJECTIVE: To observe whether several human tumor cells secret β-hCG subunit and the serum against hCG chim- eric peptide (CP22) inhibits tumor cell proliferation in vitro. METHODS: Whether five strains of human tumor cells express β-hCG were determined using immunofluorescence staining, and the optical density of tumor cells growth inhibited by anti-CP22 an- tiserum (AS CP22) and anti- β-hCG C-terminal 37 residue synthet- ic peptide serum (AS CTP) in vitro was determined using CKK-8 kit. RESULTS.. Using AS CP22 as probe and AS CTP as positive control, the green immunofluorescence on human pancreatic (BX- PC-3), ovarian (HO-8910) and colorectal (Lovo) cells were found in vitro, suggesting that these tumor cells expressed β-hCG subunit, whereas that did not observed on prostate tumor (PC-3 and Du-145) cells. Compared with normal rabbit serum, the growth of BXPC-3 and HO-8910 cells in vitro could be inhibited notably by rabbit AS CP22 and AS CTP (NS, P〈0. 001). Also, the inhibi- tory effects of AS CP22 to BXPC-3 and HO-8910 cells were better than those of AS CTP (P〈0.05) when using four different dilutions of both rabbit antisera. CONCLUSION: In five strains of human tumor cells selected in this study, the BXPC-3, HO-8910 and Lovo cells express β-hCG subunit in vitro and their growth in vitro can be inhibited by the rabbit serum to hCG CP22.
出处 《中华肿瘤防治杂志》 CAS 2011年第15期1141-1145,共5页 Chinese Journal of Cancer Prevention and Treatment
基金 国家自然科学基金(39870856 30070792)
关键词 人肿瘤细胞 Β-HCG 抗血清 免疫荧光染色 human tumor cell β-HCG antiserum immunofluorescence staining
  • 相关文献

参考文献21

  • 1韩冰,向阳,王峥,王云,张浩,黄尚志.二氢叶酸还原酶在两种不同方式诱导的甲氨蝶呤耐药绒癌细胞系中的动态表达[J].现代妇产科进展,2010,19(8):561-564. 被引量:8
  • 2王红英.血清β-人绒毛膜促性腺激素联合孕酮、血管内皮生长因子在异位妊娠早期诊断中的价值[J].中国综合临床,2011,27(4):361-362. 被引量:6
  • 3Triozzi PL, Stevens VC. Human chorionic gonadotropin as a target for cancer vaccines[J]. Oncol Rep, 1999, 6 (1): 7-17.
  • 4Jiang C, Jiang Y, Huang Z, et al. Evaluation of the immunogenicity of a single chain chimeric peptide composed of hCGβ and oLHa for inhibition of the growth of hCC-β-expressing cancer cells [J]. Cancer Immunol Immunother, 2010, 59(12):1771-1779.
  • 5Lundin M, Nordling S, Carpelan Holmstrom M, et al. A comparison of serum and tissue hCG beta as prognostic markers in colorectal cancer [J]. Anticancer Res, 2000, 20(6):4949-4951.
  • 6Naz RK, Gupta SK, Gupta JC, et al. Recent advances in contraceptive vaccine development: a mini-review [J]. Hum Reprod, 2005, 20(12):3271-3283.
  • 7He YP, Xu WX, Hong AZ, et al. Immunogenic comparison for two different recombinant chimeric peptides(CP12 and CP22) containing one or two copies of three linear B cell epitopes from β-hCG subunit [J]. J Biotechnol, 2011, 151(1):15-21.
  • 8Mungan T, Kuscu E, Ugur M, et al. Screening of persistent trophoblastie disease with various serum markers [J]. Eur J Gynaecol Oncol, 1998, 19(5):495-497.
  • 9Iles RK, Delves PJ, Butler SA. Does hCG or hCG play a role in cancer cell biology[J]. Mol Cell Endocrinol, 2010, 329 (1-2) 62-70.
  • 10Gawronska B, Leuschner C, Enright FM, et al. Effects of a lyric peptide conjugated to beta HCG on ovarian cancer: studies in vitro and in vivo[J]. Gynecol Oncol, 2002, 85 (1): 45-52.

二级参考文献76

  • 1Chang X Han J.Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors[J].中国生物学文摘,2006,20(5):5-5. 被引量:19
  • 2黄英源,邓敏端,赵翠柳,区海.动态监测血清β-绒毛膜促性腺激素对异位妊娠早期诊断的价值[J].南方医科大学学报,2006,26(6):844-846. 被引量:22
  • 3Kryezek I, Wei S, Keller E, et al. The chemokine stroma-derived factor (SDF 1/ CXCL12) plays multiple roles in tumor pathogenesis[J]. Am J Physiol Cell Physiol, 2007, 292 (3) :C987-995
  • 4Walser T C, Fulton A M. The role of chemokines in the biology and therapy of breast caneer[J]. Breast Dis, 2004, 20:137-143.
  • 5Liang Z, Yoon Y, Votaw J, et al. Silencing of CXCR4 blocks breast cancer metastasis[J]. Cancer IRes, 2005, 65 (3): 967-971.
  • 6Kato M, Kitayama J, Kazama S, et al. Expression pattern of CXC ehemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma[J]. Breast Cancer Res, 2003, 5 (5) :R144-150.
  • 7Kang H, Watkins G, Parr C, et al. Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer[J]. Breast Cancer Res, 2005, 7(4) :R402- 410.
  • 8Ohira S, Sasaki M, Harada K, et al. Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor- and stromal-derived factor 1 released in stroma [J ]. Am J Pathol, 2006, 168(4) :1155-1168.
  • 9Yasumoto K, Koizumi K, Kawashima A, et al. Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer [J]. Cancer Res, 2006, 66(4):2181-2187.
  • 10Marchesi F, Monti P, Leone B E, et al. Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4[J]. Cancer Res, 2004, 64 (22) :8420-8427.

共引文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部